Oct 2026
Discovery of Pyrazolopyrimidines as Potent and Orally Bioavailable MRGPRX2 Antagonists
The discovery of a pyrazolopyrimidine series as potent and orally bioavailable MRGPRX2 antagonists and establish the pyrazolopyrimidine chemotype as a promising scaffold for inhibition of MRGPRX2 signaling are established.
Minh-Hai Nguyen, Hai-Fen Ye, Heeoon Han et al.
· ACS Medicinal Chemistry Lett... · 0 citations